Evidence map›Paper›PMID 35987857›Full record

ArticleTrials2022

Effectiveness of an expert assessment and individualised treatment compared with a minimal home-based exercise program in women with late-term shoulder impairments after primary breast cancer surgery: study protocol for a randomised controlled trial.

Kim Michéle Feder, Hans Bjarke Rahr, Marianne Djernes Lautrup, Heidi Klakk Egebæk, Robin Christensen, Kim Gordon Ingwersen

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05277909 (Effectiveness of an Expert Assessment and Individualised Treatment in Comparison to a Minimal Home-based Exercise Program in Women With Late-term Shoulder Impairments After Primary Breast Cancer Surgery.), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05277909 nacompletednot on this map

Effectiveness of an Expert Assessment and Individualised Treatment in Comparison to a Minimal Home-based Exercise Program in Women With Late-term Shoulder Impairments After Primary Breast Cancer Surgery.

TypeinterventionalSponsorVejle HospitalRan2022 to 2022Enrolled31ConditionsShoulder Pain, Late Effect, Breast Cancer, RehabilitationArmsThe expert assessment of shoulder impairments and individualised treatment plan, A minimal physiotherapeutic rehabilitation program delivered in a pamphlet
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kim Michéle FederDepartment of Physiotherapy, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark. kim.michele.feder@rsyd.dk.ORCID http://orcid.org/0000-0003-3088-1833
Hans Bjarke RahrDepartment of Regional Health Research, University of Southern Denmark, 5230, J.B. Winsløws Vej 19, Odense M, Denmark.
Marianne Djernes LautrupDepartment of Surgery, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
Heidi Klakk EgebækResearch Unit for Applied Health Science, University College South (UC SYD), Lembckesvej 3-7, 6100, Haderslev, Denmark.
Robin ChristensenSection for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Nordre Fasanvej 57, 2000, Frederiksberg, Denmark.
Kim Gordon IngwersenDepartment of Physiotherapy, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark.
University of Southern Denmark · DKAarhus University Hospital · DK

Funding

Fru Astrid Thaysens Legat for Lægevidenskabelig Grundforskning ATL 19/03Hospital Lillebaelt (SLB Forskningsråd) 2020-13Region of Southern Denmark 19/12125
6 · The paper itself

Abstract

backgroundIn breast cancer patients, late-term upper limb sequelae, such as shoulder pain and impaired shoulder function, remain common after primary breast cancer surgery. The aim of this trial is to evaluate whether an expert assessment of shoulder impairments, followed by an individualised treatment plan, is superior to a minimal physiotherapeutic rehabilitation program in reducing shoulder symptoms, among women with late-term shoulder impairments after primary breast cancer. METHODS/

designThe study is designed as a stratified, parallel-group, assessor-blinded, randomised, controlled trial conducted in Denmark; 130 participants with late-term shoulder impairments 3-7 years after primary surgery for breast cancer will be recruited. Participants will be randomised (allocation 1:1) to either an expert assessment of shoulder impairments followed by an individualised treatment plan or to follow a minimal physiotherapeutic rehabilitation program delivered in a pamphlet. The primary outcome will be a change in shoulder pain and function from baseline to 12 weeks after initiating the treatment, as measured by the patient-reported outcome Shoulder Pain and Disability Index (SPADI) questionnaire. DISCUSSION: There has been an insufficient focus in research and clinical practice on late-term shoulder impairment in women following surgery for breast cancer. This trial will focus on interventions towards late-term shoulder impairments and is expected to provide evidence-based knowledge to physiotherapists and women about the management of shoulder pain and impaired shoulder function.

trial registrationClinicalTrials.gov NCT05277909. Registered on 11 March 2022.

Indexed as

Breast NeoplasmsExercise TherapyShoulder PainFemaleHumansRandomized Controlled Trials as TopicTreatment OutcomeBreast cancerLate-term shoulder impairmentsRandomised controlled trialRehabilitationStudy protocol

Identifiers

PMID35987857
PMCPMC9392220
OpenAlexW4293105467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.